Stocktoria
PULSE BIOSCIENCES, INC. PLSE
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2016-05-18
PULSE BIOSCIENCES, INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $350,000 | $0 | $0 | $700,000 | $1.4M |
| R&D expense | $44.7M | $32.3M | $27.8M | $20.8M | $28.6M |
| SG&A expense | $32.0M | $23.9M | — | — | — |
| Operating income | -$76.9M | -$56.3M | -$43.6M | -$58.1M | -$63.0M |
| Income tax | $0 | $0 | $0 | $0 | $0 |
| Net income | -$72.8M | -$53.6M | -$42.2M | -$58.5M | -$63.7M |
| Operating cash flow | -$54.1M | -$36.3M | -$33.0M | -$47.0M | -$54.1M |
| Free cash flow | -$54.4M | -$36.5M | -$33.2M | -$47.4M | -$54.5M |
| Cash & equivalents | $80.7M | $118.0M | $44.4M | $61.1M | $44.4M |
| Inventory | $136,000 | $0 | — | $0 | $5.8M |
| Total assets | $94.5M | $132.5M | $59.2M | $77.9M | $59.2M |
| Total liabilities | $13.9M | $17.6M | $14.8M | $80.1M | $14.8M |
| Shareholders' equity | $80.7M | $114.9M | $44.4M | -$2.2M | $44.4M |
Source: SEC EDGAR filings · CIK 0001625101 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.